Cargando…
Lower Patient Anxiety and Unchanged Levels of Adherence to Hemato-Oncologic Treatment in Response to New Measures to Reduce Hospital Exposure Risk to COVID-19
OBJECTIVE: Hemato-oncology patients are at high risk for morbidity and mortality from coronavirus disease (COVID-19). The resultant heightened anxiety among these patients may negatively affect adherence to therapy and treatment-related outcome. We aimed to assess whether the adoption of precautiona...
Autores principales: | Sarid, Nadav, Mann, Shir, Herishanu, Yair, Perry, Chava, Cohen, Yael C, Passage, Inna, Neaman, Miriam, Benyamini, Noam, Jean, Maayan, Avivi, Irit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8122002/ https://www.ncbi.nlm.nih.gov/pubmed/34007160 http://dx.doi.org/10.2147/PPA.S307561 |
Ejemplares similares
-
COVID-19 in patients with lymphoproliferative diseases during the Omicron variant surge
por: Bronstein, Yotam, et al.
Publicado: (2022) -
Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy
por: Cohen, Dan, et al.
Publicado: (2021) -
REGEN‐COV antibody combination in patients with lymphoproliferative malignancies and SARS‐CoV‐2 infection
por: Bronstein, Yotam, et al.
Publicado: (2022) -
The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma
por: Perry, Chava, et al.
Publicado: (2016) -
Is There a Role for [(18)F]FDG PET-CT in Staging MALT Lymphoma?
por: Cohen, Dan, et al.
Publicado: (2022)